Company profile NCNA
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. NuCana expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 40 | 26 -35.0% QoQ | 55 111.5% QoQ | 48 -12.7% QoQ |
| 2020 | 154 285.0% YoY 220.8% QoQ | 98 276.9% YoY -36.4% QoQ | 123 123.6% YoY 25.5% QoQ | 93 93.8% YoY -24.4% QoQ |
| 2021 | 259 68.2% YoY 178.5% QoQ | 105 7.1% YoY -59.5% QoQ | 103 -16.3% YoY -1.9% QoQ | 330 254.8% YoY 220.4% QoQ |
| 2022 | 195 -24.7% YoY -40.9% QoQ | 62 -41.0% YoY -68.2% QoQ | 102 -1.0% YoY 64.5% QoQ | 78 -76.4% YoY -23.5% QoQ |
| 2023 | 127 -34.9% YoY 62.8% QoQ | 20 -67.7% YoY -84.3% QoQ | 27 -73.5% YoY 35.0% QoQ | 89 14.1% YoY 229.6% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of NuCana was 8.18 per week. The last year interest of NuCana compared to the last 5 years has changed by -53.42%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 10.76%.
There is not enough data for NuCana biopharmaceutical to provide analysis
There is not enough data for NuCana biopharmaceutical to provide correlation calculation
There is not enough data for NuCana biopharmaceutical to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. NuCana stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 37 inf% QoQ | 40 8.1% QoQ | 0 -100.0% QoQ |
| 2020 | 138 inf% YoY inf% QoQ | 53 43.2% YoY -61.6% QoQ | 93 132.5% YoY 75.5% QoQ | 92 inf% YoY -1.1% QoQ |
| 2021 | 269 94.9% YoY 192.4% QoQ | 183 245.3% YoY -32.0% QoQ | 110 18.3% YoY -39.9% QoQ | 324 252.2% YoY 194.5% QoQ |
| 2022 | 194 -27.9% YoY -40.1% QoQ | 53 -71.0% YoY -72.7% QoQ | 176 60.0% YoY 232.1% QoQ | 102 -68.5% YoY -42.0% QoQ |
| 2023 | 100 -48.5% YoY -2.0% QoQ | 13 -75.5% YoY -87.0% QoQ | 75 -57.4% YoY 476.9% QoQ | 128 25.5% YoY 70.7% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of NuCana stock was 8.35 per week. The last year interest of NuCana stock compared to the last 5 years has changed by -40.36%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 236.49%.
There is not enough data for NuCana ProTide technology to provide analysis
There is not enough data for NuCana ProTide technology to provide correlation calculation
There is not enough data for NuCana ProTide technology to provide analysis
There is not enough data for NuCana cancer treatment to provide analysis
There is not enough data for NuCana cancer treatment to provide correlation calculation
There is not enough data for NuCana cancer treatment to provide analysis
There is not enough data for NuCana NUC-3373 to provide analysis
There is not enough data for NuCana NUC-3373 to provide correlation calculation
There is not enough data for NuCana NUC-3373 to provide analysis
There is not enough data for NuCana NUC-7738 to provide analysis
There is not enough data for NuCana NUC-7738 to provide correlation calculation
There is not enough data for NuCana NUC-7738 to provide analysis
Google Trends for NuCana clinical-stage biopharmaceutical
Not enough data for reliable calculations!
There is not enough data for NuCana clinical-stage biopharmaceutical to provide analysis
There is not enough data for NuCana clinical-stage biopharmaceutical to provide correlation calculation
There is not enough data for NuCana clinical-stage biopharmaceutical to provide analysis
There is not enough data for NuCana Edinburgh to provide analysis
There is not enough data for NuCana Edinburgh to provide correlation calculation
There is not enough data for NuCana Edinburgh to provide analysis
There is not enough data for NuCana healthcare biotechnology. to provide analysis
There is not enough data for NuCana healthcare biotechnology. to provide correlation calculation
There is not enough data for NuCana healthcare biotechnology. to provide analysis